Unintended Consequences Repurcussions of Nuke Initiative Imperil Nascent Biotech Industry

Summary

---

Consider the Richland company that has refined a treatment for prostate cancer so the patient suffers fewer side effects. The first patient received the treatment in November at the University of Washington Medical Center and four others have since then. Doctors are excited about the prospects.

It's biotech. It's cutting edge. It's just the kind of industry we want more of in Washington state.

See the full content of this document

Extract

---

Unintended Consequences Repurcussions of Nuke Initiative Imperil Nascent Biotech Industry

Now consider that IsoRay Medical has halted site engineering work for its new $10 million production plant and put on hold its plans to expand its work force from 16 to 250.

The good work of IsoRay -- and its potential econo...

See the full content of this document

---